Lijoy K. Mathew

2.1k total citations · 1 hit paper
25 papers, 1.6k citations indexed

About

Lijoy K. Mathew is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Lijoy K. Mathew has authored 25 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Cell Biology. Recurrent topics in Lijoy K. Mathew's work include Zebrafish Biomedical Research Applications (6 papers), Developmental Biology and Gene Regulation (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Lijoy K. Mathew is often cited by papers focused on Zebrafish Biomedical Research Applications (6 papers), Developmental Biology and Gene Regulation (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Lijoy K. Mathew collaborates with scholars based in United States, Slovakia and France. Lijoy K. Mathew's co-authors include Robert L. Tanguay, Eric A. Andreasen, M. Celeste Simon, Brian Keith, S. Sengupta, Bo Qiu, Bo Li, Zandra E. Walton, Itzhak Nissim and Anthony Mancuso and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Lijoy K. Mathew

25 papers receiving 1.6k citations

Hit Papers

Fructose-1,6-bisphosphatase opposes renal carcinoma progr... 2014 2026 2018 2022 2014 100 200 300 400

Peers

Lijoy K. Mathew
Kathryn Bambino United States
M. Celeste Simon United States
Marzia Scortegagna United States
Ching Shang United States
Govind Gawdi United States
Daryl J. Discher United States
John Herbert United Kingdom
Cheryl L. Walker United States
Keirnan Willett United States
Lijoy K. Mathew
Citations per year, relative to Lijoy K. Mathew Lijoy K. Mathew (= 1×) peers Mayuko Kato

Countries citing papers authored by Lijoy K. Mathew

Since Specialization
Citations

This map shows the geographic impact of Lijoy K. Mathew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijoy K. Mathew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijoy K. Mathew more than expected).

Fields of papers citing papers by Lijoy K. Mathew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijoy K. Mathew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijoy K. Mathew. The network helps show where Lijoy K. Mathew may publish in the future.

Co-authorship network of co-authors of Lijoy K. Mathew

This figure shows the co-authorship network connecting the top 25 collaborators of Lijoy K. Mathew. A scholar is included among the top collaborators of Lijoy K. Mathew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijoy K. Mathew. Lijoy K. Mathew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fuchs, Charles S., Javad Shahidi, Lijoy K. Mathew, A. Qin, & Eric Van Cutsem. (2020). P-184 A phase 2 trial of trastuzumab deruxtecan (T-DXd, DS-8201) in patients with HER2-positive, unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma. Annals of Oncology. 31. S150–S150. 1 indexed citations
2.
Sengupta, S., Lijoy K. Mathew, Lisa Truong, et al.. (2019). Glucocorticoid receptor-dependent induction of cripto-1 (one-eyed pinhead) inhibits zebrafish caudal fin regeneration. Toxicology Reports. 6. 529–537. 10 indexed citations
3.
Wyce, Anastasia, Shawn W. Foley, Satyajit Rajapurkar, et al.. (2018). MEK inhibitors overcome resistance to BET inhibition across a number of solid and hematologic cancers. Oncogenesis. 7(4). 35–35. 23 indexed citations
4.
Walsh, Alice M., Gurpreet S. Kapoor, Janine M. Buonato, et al.. (2015). Sprouty2 Drives Drug Resistance and Proliferation in Glioblastoma. Molecular Cancer Research. 13(8). 1227–1237. 24 indexed citations
5.
Mathew, Lijoy K., Peiwei Huangyang, Vera Mucaj, et al.. (2015). Feedback circuitry between miR-218 repression and RTK activation in glioblastoma. Science Signaling. 8(375). ra42–ra42. 20 indexed citations
6.
Li, Bo, Bo Qiu, David S.M. Lee, et al.. (2014). Fructose-1,6-bisphosphatase opposes renal carcinoma progression. Nature. 513(7517). 251–255. 404 indexed citations breakdown →
7.
Buonato, Janine M., Nicolas Skuli, Lijoy K. Mathew, et al.. (2014). Multivariate signaling regulation by SHP2 differentially controls proliferation and therapeutic response in glioma cells. Journal of Cell Science. 127(Pt 16). 3555–67. 42 indexed citations
8.
Mucaj, Vera, N. Skuli, Bo Qiu, et al.. (2014). MicroRNA-124 expression counteracts pro-survival stress responses in glioblastoma. Oncogene. 34(17). 2204–2214. 53 indexed citations
9.
Mathew, Lijoy K., Samuel S. Lee, Nicolas Skuli, et al.. (2013). Restricted Expression of miR-30c-2-3p and miR-30a-3p in Clear Cell Renal Cell Carcinomas Enhances HIF2α Activity. Cancer Discovery. 4(1). 53–60. 68 indexed citations
10.
Mathew, Lijoy K., Nicolas Skuli, Vera Mucaj, et al.. (2013). miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma. Proceedings of the National Academy of Sciences. 111(1). 291–296. 88 indexed citations
11.
Sengupta, S., William H. Bisson, Lijoy K. Mathew, Siva K. Kolluri, & Robert L. Tanguay. (2012). Alternate glucocorticoid receptor ligand binding structures influence outcomes in an in vivo tissue regeneration model. Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology. 156(2). 121–129. 19 indexed citations
12.
Skuli, Nicolas, Amar J. Majmundar, Bryan L. Krock, et al.. (2012). Endothelial HIF-2α regulates murine pathological angiogenesis and revascularization processes. Journal of Clinical Investigation. 122(4). 1427–1443. 163 indexed citations
13.
Gruber, Michaela, Lijoy K. Mathew, Anja Runge, Joseph A. Garcia, & M. Celeste Simon. (2010). EPAS1 Is Required for Spermatogenesis in the Postnatal Mouse Testis1. Biology of Reproduction. 82(6). 1227–1236. 29 indexed citations
14.
O’Donnell, Edmond F., Katerine S. Saili, Daniel C. Koch, et al.. (2010). The Anti-Inflammatory Drug Leflunomide Is an Agonist of the Aryl Hydrocarbon Receptor. PLoS ONE. 5(10). e13128–e13128. 101 indexed citations
15.
Mathew, Lijoy K., S. Sengupta, Jill A. Franzosa, et al.. (2009). Comparative Expression Profiling Reveals an Essential Role for Raldh2 in Epimorphic Regeneration. Journal of Biological Chemistry. 284(48). 33642–33653. 68 indexed citations
16.
Mathew, Lijoy K., et al.. (2008). AHR-dependent misregulation of Wnt signaling disrupts tissue regeneration. Biochemical Pharmacology. 77(4). 498–507. 45 indexed citations
17.
Mathew, Lijoy K., S. Sengupta, Atsushi Kawakami, et al.. (2007). Unraveling Tissue Regeneration Pathways Using Chemical Genetics. Journal of Biological Chemistry. 282(48). 35202–35210. 140 indexed citations
18.
Andreasen, Eric A., Lijoy K. Mathew, & Robert L. Tanguay. (2006). Regenerative Growth Is Impacted by TCDD: Gene Expression Analysis Reveals Extracellular Matrix Modulation. Toxicological Sciences. 92(1). 254–269. 58 indexed citations
19.
Andreasen, Eric A., et al.. (2006). Aryl Hydrocarbon Receptor Activation Impairs Extracellular Matrix Remodeling during Zebra Fish fin Regeneration. Toxicological Sciences. 95(1). 215–226. 50 indexed citations
20.
Mathew, Lijoy K., Eric A. Andreasen, & Robert L. Tanguay. (2005). Aryl Hydrocarbon Receptor Activation Inhibits Regenerative Growth. Molecular Pharmacology. 69(1). 257–265. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026